Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genome-Wide Discovery Reveals Adipose-Specific and Systemic Regulators of Insulin Resistance.

medRxiv : the preprint server for health sciences·2026

Same author

Extensive enhancer crosstalk controls PPARG2 activation during adipogenesis.

Nature communications·2026

Same author

Functional dissection of complex trait variants at single-nucleotide resolution.

Nature·2026

Same author

Multiplexed high-content imaging uncovers morphological diversity of lymphocyte activation and dysfunction.

bioRxiv : the preprint server for biology·2026

Same author

Multi-omics profiling of cachexia-targeted tissues reveals a spatio-temporally coordinated response to cancer.

Nature metabolism·2026

Same author

The <i>9p21.3</i> Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of <i>MTAP</i>.

bioRxiv : the preprint server for biology·2025

Search research articles

Related Experiment Video

Updated: Jan 10, 2026

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

Bridging the variant-to-function gap in type 2 diabetes: advances and challenges.

Adam G Maynard^1,2, Raghav Bhardwaj^1,2, Thouis R Jones^1,2,3

¹Broad Institute of MIT and Harvard, Cambridge, MA, USA.

|November 22, 2025

Summary

New strategies are linking genetic variants to specific gene functions, improving our understanding of type 2 diabetes mechanisms. This research helps bridge the gap between genetic discoveries and biological insights for precision medicine.

Keywords:

CRISPR GWAS Genetics Multi-omics Precision medicine Review Type 2 diabetes Variant-to-function

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Related Experiment Videos

Last Updated: Jan 10, 2026

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Area of Science:

Genetics
Metabolic Diseases
Molecular Biology

Background:

Type 2 diabetes affects over 530 million globally, with numbers projected to reach 1.3 billion by 2050.
Genome-wide association studies identified over 1200 type 2 diabetes loci, but most risk variants are in non-coding regions, hindering biological interpretation and explaining limited heritability.

Purpose of the Study:

To review advances in variant-to-function (V2F) strategies for linking non-coding genetic variants to molecular mechanisms in type 2 diabetes.
To highlight V2F discoveries in key type 2 diabetes-related tissues and discuss emerging tools for precision medicine.

Main Methods:

Fine-mapping
Chromatin profiling
Single-cell multi-omics
Scalable CRISPR-based perturbation strategies
Machine learning tools

Main Results:

V2F strategies are beginning to link non-coding variants to effector genes, tissues, and molecular mechanisms.
Specific examples include TCF7L2 in pancreatic beta cells, SLC16A11 and PNPLA3 in hepatocytes, and GLUT4 trafficking in adipocytes and muscle.
A summary table of V2F discoveries and a discussion of emerging tools are provided.

Conclusions:

Recent V2F advances are crucial for understanding the biological basis of type 2 diabetes genetic risk.
These developments are essential for addressing disease heterogeneity and paving the way for precision medicine approaches.